Suppr超能文献

Csk对Src的抑制作用涉及Csk向Src活性位点的移动。

Csk suppression of Src involves movement of Csk to sites of Src activity.

作者信息

Howell B W, Cooper J A

机构信息

Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

出版信息

Mol Cell Biol. 1994 Aug;14(8):5402-11. doi: 10.1128/mcb.14.8.5402-5411.1994.

Abstract

Csk phosphorylates Src family members at a key regulatory tyrosine in the C-terminal tail and suppresses their activities. It is not known whether Csk activity is regulated. To examine the features of Csk required for Src suppression, we expressed Csk mutants in a cell line with a disrupted csk gene. Expression of wild-type Csk suppressed Src, but Csk with mutations in the SH2, SH3, and catalytic domains did not suppress Src. An SH3 deletion mutant of Csk was fully active against in vitro substrates, but two SH2 domain mutants were essentially inactive. Whereas Src repressed by Csk was predominantly perinuclear, the activated Src in cells lacking Csk was localized to structures resembling podosomes. Activated mutant Src was also in podosomes, even in the presence of Csk. When Src was not active, Csk was diffusely located in the cytosol, but when Src was active, Csk colocalized with activated Src to podosomes. Csk also localizes to podosomes of cells transformed by an activated Src that lacks the major tyrosine autophosphorylation site, suggesting that the relocalization of Csk is not a consequence of the binding of the Csk SH2 domain to phosphorylated Src. A catalytically inactive Csk mutant also localized with Src to podosomes, but SH3 and SH2 domain mutants did not, suggesting that the SH3 and SH2 domains are both necessary to target Csk to places where Src is active. The failure of the catalytically active SH3 mutant of Csk to regulate Src may be due to its inability to colocalize with active Src.

摘要

Csk在C末端尾巴的一个关键调节性酪氨酸位点使Src家族成员磷酸化,从而抑制它们的活性。目前尚不清楚Csk的活性是否受到调节。为了研究抑制Src所需的Csk的特征,我们在一个csk基因被破坏的细胞系中表达Csk突变体。野生型Csk的表达抑制了Src,但SH2、SH3和催化结构域发生突变的Csk则不能抑制Src。Csk的一个SH3缺失突变体对体外底物具有完全活性,但两个SH2结构域突变体基本无活性。虽然被Csk抑制的Src主要位于核周,但缺乏Csk的细胞中活化的Src定位于类似于小体的结构。即使存在Csk,活化的突变型Src也存在于小体中。当Src无活性时,Csk分散地位于细胞质中,但当Src有活性时,Csk与活化的Src共定位于小体。Csk也定位于由缺乏主要酪氨酸自磷酸化位点的活化Src转化的细胞的小体,这表明Csk的重新定位不是Csk SH2结构域与磷酸化Src结合的结果。一个催化无活性的Csk突变体也与Src共定位于小体,但SH3和SH2结构域突变体则不然,这表明SH3和SH2结构域对于将Csk靶向Src有活性的位置都是必需的。Csk的催化活性SH3突变体无法调节Src可能是由于其无法与活性Src共定位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b41/359059/aa87138a32dd/molcellb00008-0396-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验